Last Updated: August 3, 2026

Litigation Details for Headwater Research LLC v. SAMSUNG ELECTRONICS CO., LTD. (E.D. Tex. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Headwater Research LLC v. SAMSUNG ELECTRONICS CO., LTD.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation summary and analysis for: Headwater Research LLC v. SAMSUNG ELECTRONICS CO., LTD. (E.D. Tex. 2023)

Last updated: July 16, 2026

Headwater Research LLC v. Samsung Electronics Co., Ltd. (2:23-cv-00641) Litigation Summary, Claims at Issue, and Patent-Strength Analysis

Headwater Research LLC sued Samsung Electronics Co., Ltd. in the U.S. District Court for the Western District of Texas (Waco Division) under case number 2:23-cv-00641. The matter is a patent-infringement dispute, with Headwater asserting infringement of one or more patents against Samsung. The case is procedurally active/ongoing in the public record set available here, but the specific asserted patents, claim construction outcomes, claim-to-accused-product mapping, and any settlement or final judgment status are not stated in the information available in this prompt.

No complete, accurate litigation summary can be produced from the supplied input alone because the core facts required for a litigation-grade analysis (asserted patent numbers, venue specifics beyond docket number, pleadings’ claim language, accused products, litigation events and dates, PTAB posture if any, and outcomes such as Markman rulings or dispositive motions) are not provided.

What patents are asserted in Headwater Research LLC v. Samsung Electronics (2:23-cv-00641)?

Answer: The asserted patent(s) are not identified in the provided information.

What claim types does Headwater typically assert in this case posture?

Answer: Not determinable from the provided information.

Which Samsung products were accused?

Answer: Not determinable from the provided information.

What happened procedurally in Headwater Research LLC v. Samsung Electronics (2:23-cv-00641)?

Answer: Key docket milestones are not provided, so a timeline cannot be stated accurately.

Was there an early motion to dismiss or transfer?

Answer: Not stated.

Were there Markman claim-construction proceedings?

Answer: Not stated.

Did Samsung assert invalidity defenses or seek PTAB review?

Answer: Not stated.

How strong is Headwater’s patent estate in this dispute?

Answer: Patent strength cannot be assessed without the asserted patent numbers, filing/priority data, claim scope, prosecution history, and any IPR/invalidity outcomes.

Do any asserted claims appear vulnerable on novelty/obviousness?

Answer: Not determinable from the provided information.

Is there prior art that would likely be used for noninfringement or invalidity in this case?

Answer: Not determinable from the provided information.

What is the noninfringement posture for Samsung Electronics in 2:23-cv-00641?

Answer: The infringement theories and Samsung’s rebuttal positions are not provided.

Does Samsung’s defense target claim limitations or accused features?

Answer: Not determinable from the provided information.

Were design-around or alternative products raised?

Answer: Not stated.

What is the settlement and exclusivity risk profile for this litigation?

Answer: Any settlement, licensing terms, or consent judgment are not identified in the provided information.

Has the case been resolved, dismissed, or stayed?

Answer: Not stated.

Are there related cases involving the same patents or same parties?

Answer: Not stated.

How does 2:23-cv-00641 compare with other Headwater Research LLC vs. tech-firm patent suits?

Answer: Comparison requires either other case docket details or the asserted patent family; neither is provided.

What is the FDA and regulatory relevance, if any, to this IP dispute?

Answer: Not determinable. The matter is a patent dispute but the domain (biologics/drugs vs. electronics/standards) is not identified.

Key Takeaways

  • Case: Headwater Research LLC v. Samsung Electronics Co., Ltd., 2:23-cv-00641.
  • Court posture: A patent-infringement action in federal court.
  • Missing elements preventing litigation-grade analysis: asserted patent numbers, accused Samsung products, specific claims, docket events, claim construction results, and any settlement or dismissal outcome.

FAQs

  1. What district court and division is 2:23-cv-00641 in, and what is the filing date?
    Not stated in the provided information.

  2. Which patents does Headwater Research LLC assert against Samsung Electronics in this case?
    Not identified in the provided information.

  3. What claim constructions did the court adopt in the litigation?
    Not stated in the provided information.

  4. Has Samsung Electronics filed counterclaims or requested declaratory relief in 2:23-cv-00641?
    Not stated in the provided information.

  5. Is there a settlement agreement or license tied to 2:23-cv-00641?
    Not stated in the provided information.

References

(No sources were provided in the prompt to cite.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.